{"id":11725,"date":"2021-01-07T10:01:36","date_gmt":"2021-01-07T09:01:36","guid":{"rendered":"https:\/\/www.ship2b.org\/?p=11725"},"modified":"2025-02-08T01:13:53","modified_gmt":"2025-02-08T00:13:53","slug":"ship2b-invierte-devicare","status":"publish","type":"post","link":"https:\/\/www.ship2b.org\/en\/actualidad\/ship2b-invierte-devicare\/","title":{"rendered":"Ship2B participa en la ronda de inversi\u00f3n de tres millones de d\u00f3lares que cierra Devicare"},"content":{"rendered":"<p><strong>Ship2B, a trav\u00e9s de nuestro veh\u00edculo de inversi\u00f3n <a href=\"https:\/\/www.ship2b.org\/inversion\/\" target=\"_blank\" rel=\"noopener noreferrer\">Equity4Good<\/a><\/strong> -cofinanciado por el Fondo Europeo de Inversiones-, participa en la <strong>ronda de inversi\u00f3n de tres millones de d\u00f3lares que cierra <a href=\"https:\/\/www.devicare.com\/en\/\" target=\"_blank\" rel=\"noopener noreferrer\">Devicare<\/a><\/strong>, startup que desarrolla un innovador tratamiento urol\u00f3gico que combina combina terapia nutricional con monitorizaci\u00f3n digitalizada. Esta ronda est\u00e1 <strong>liderada por Advanced MedTech Holdings<\/strong> (AMTH), el grupo de dispositivos m\u00e9dicos m\u00e1s grande del Sureste Asi\u00e1tico, y tambi\u00e9n <strong>han participado en ella los principales socios de Davicare, EMESA Capital, Juan Knuth y su fundador Rosendo Garganta<\/strong>.<\/p>\n<p>El dinero se utilizar\u00e1 para <strong>continuar desarrollando la soluci\u00f3n Lit-Control\u00ae indicada para el tratamiento de los pacientes con c\u00e1lculos renales,<\/strong> compuesta por un pH meter conectado v\u00eda Bluetooth\u00ae a una aplicaci\u00f3n m\u00f3vil. Este pH meter digital est\u00e1 espec\u00edficamente dise\u00f1ado para <strong>ofrecer una medicina personalizada a trav\u00e9s de la medida del pH urinario de los pacientes y la recomendaci\u00f3n de la correcta medicaci\u00f3n<\/strong>, que luego mediante la transmisi\u00f3n de datos a una app y el <strong>uso de algoritmos informatizados permitir\u00e1 ajustar su dosis y posolog\u00eda<\/strong> para que el tratamiento sea m\u00e1s eficaz, y permitir\u00e1 a los ur\u00f3logos y sus pacientes gestionar la enfermedad de manera remota.<\/p>\n<h3><strong>Terapia digital avanzada<\/strong><\/h3>\n<p>Este dispositivo m\u00e9dico conectado es la segunda generaci\u00f3n del innovador Lit-Control\u00ae pH Meter de Devicare, que dispone de la misma tecnolog\u00eda de sensores de silicio pero incorpora nuevas caracter\u00edsticas y funcionalidades con los que poder ofrecer una terapia digital m\u00e1s avanzada. Este producto se unir\u00e1 a los nutrac\u00e9uticos Lit-Control\u00ae que conforman la terapia nutricional m\u00e1s completa del mercado para tratar todos los tipos de c\u00e1lculos renales, y que ya est\u00e1n <strong>presentes en pa\u00edses como Espa\u00f1a, Portugal, Francia, UK, y Estados Unidos<\/strong>, entre otros.<\/p>\n<p><strong>Rosendo Garganta, fundador y consejero delegado de Devicare<\/strong>, asegura que \u201cnuestra m\u00e1xima prioridad siempre ha sido empoderar a los pacientes y ayudarles a gestionar mejor su salud urol\u00f3gica. Los c\u00e1lculos renales tienen una tasa de recurrencia de entre el 60-80% en los pacientes, lo que supone un importante obst\u00e1culo para ellos y una merma en su calidad de vida. Este acuerdo estrat\u00e9gico con Advanced MedTech nos permitir\u00e1 acelerar el desarrollo de nuestra tecnolog\u00eda para ofrecer a los ur\u00f3logos y sus pacientes una medicina m\u00e1s personalizada, usando herramientas digitales, que les permitan tratar la enfermedad de manera m\u00e1s eficaz y coste-efectiva&#8221;.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ship2B, a trav\u00e9s de nuestro veh\u00edculo de inversi\u00f3n Equity4Good -cofinanciado por el Fondo Europeo de Inversiones-, participa en la ronda de inversi\u00f3n de tres millones de d\u00f3lares que cierra Devicare, startup que desarrolla un innovador tratamiento urol\u00f3gico que combina combina terapia nutricional con monitorizaci\u00f3n digitalizada. Esta ronda est\u00e1 liderada por Advanced MedTech Holdings (AMTH), el &hellip; <a href=\"https:\/\/www.ship2b.org\/en\/actualidad\/ship2b-invierte-devicare\/\">Read more<\/a><\/p>\n","protected":false},"author":3,"featured_media":11726,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[21,23],"tags":[302],"class_list":["post-11725","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ship2b","category-inversion-de-impacto","tag-devicare"],"acf":[],"yoast_head":"<title>Ship2B invierte en Devicare a trav\u00e9s de Equity4Good | Ship2B Foundation<\/title>\n<meta name=\"description\" content=\"Ship2B, a trav\u00e9s de Equity4Good, participa en la ronda de inversi\u00f3n de 3 millones de Devicare, startup que desarrolla un innovador tratamiento urol\u00f3gico.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ship2B invierte en Devicare a trav\u00e9s de Equity4Good | Ship2B Foundation\" \/>\n<meta property=\"og:description\" content=\"Ship2B, a trav\u00e9s de Equity4Good, participa en la ronda de inversi\u00f3n de 3 millones de Devicare, startup que desarrolla un innovador tratamiento urol\u00f3gico.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/\" \/>\n<meta property=\"og:site_name\" content=\"Ship2B Foundation\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T09:01:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-08T00:13:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ship2b.org\/wp-content\/uploads\/2021\/01\/POR_DEVICARE.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/\",\"url\":\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/\",\"name\":\"Ship2B invierte en Devicare a trav\u00e9s de Equity4Good | Ship2B Foundation\",\"isPartOf\":{\"@id\":\"https:\/\/www.ship2b.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ship2b.org\/wp-content\/uploads\/2021\/01\/POR_DEVICARE.jpg\",\"datePublished\":\"2021-01-07T09:01:36+00:00\",\"dateModified\":\"2025-02-08T00:13:53+00:00\",\"author\":{\"@id\":\"\"},\"description\":\"Ship2B, a trav\u00e9s de Equity4Good, participa en la ronda de inversi\u00f3n de 3 millones de Devicare, startup que desarrolla un innovador tratamiento urol\u00f3gico.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#primaryimage\",\"url\":\"https:\/\/www.ship2b.org\/wp-content\/uploads\/2021\/01\/POR_DEVICARE.jpg\",\"contentUrl\":\"https:\/\/www.ship2b.org\/wp-content\/uploads\/2021\/01\/POR_DEVICARE.jpg\",\"width\":800,\"height\":400,\"caption\":\"Equity4Good invierte en Devicare\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.ship2b.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ship2B participa en la ronda de inversi\u00f3n de tres millones de d\u00f3lares que cierra Devicare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ship2b.org\/#website\",\"url\":\"https:\/\/www.ship2b.org\/\",\"name\":\"Ship2B Foundation\",\"description\":\"Adventurers for a better world\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ship2b.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/www.ship2b.org\/en\/actualidad\/author\/\"}]}<\/script>","yoast_head_json":{"title":"Ship2B invierte en Devicare a trav\u00e9s de Equity4Good | Ship2B Foundation","description":"Ship2B, a trav\u00e9s de Equity4Good, participa en la ronda de inversi\u00f3n de 3 millones de Devicare, startup que desarrolla un innovador tratamiento urol\u00f3gico.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/","og_locale":"en_US","og_type":"article","og_title":"Ship2B invierte en Devicare a trav\u00e9s de Equity4Good | Ship2B Foundation","og_description":"Ship2B, a trav\u00e9s de Equity4Good, participa en la ronda de inversi\u00f3n de 3 millones de Devicare, startup que desarrolla un innovador tratamiento urol\u00f3gico.","og_url":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/","og_site_name":"Ship2B Foundation","article_published_time":"2021-01-07T09:01:36+00:00","article_modified_time":"2025-02-08T00:13:53+00:00","og_image":[{"width":800,"height":400,"url":"https:\/\/www.ship2b.org\/wp-content\/uploads\/2021\/01\/POR_DEVICARE.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Written by":"","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/","url":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/","name":"Ship2B invierte en Devicare a trav\u00e9s de Equity4Good | Ship2B Foundation","isPartOf":{"@id":"https:\/\/www.ship2b.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#primaryimage"},"image":{"@id":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ship2b.org\/wp-content\/uploads\/2021\/01\/POR_DEVICARE.jpg","datePublished":"2021-01-07T09:01:36+00:00","dateModified":"2025-02-08T00:13:53+00:00","author":{"@id":""},"description":"Ship2B, a trav\u00e9s de Equity4Good, participa en la ronda de inversi\u00f3n de 3 millones de Devicare, startup que desarrolla un innovador tratamiento urol\u00f3gico.","breadcrumb":{"@id":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#primaryimage","url":"https:\/\/www.ship2b.org\/wp-content\/uploads\/2021\/01\/POR_DEVICARE.jpg","contentUrl":"https:\/\/www.ship2b.org\/wp-content\/uploads\/2021\/01\/POR_DEVICARE.jpg","width":800,"height":400,"caption":"Equity4Good invierte en Devicare"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ship2b.org\/actualidad\/ship2b-invierte-devicare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.ship2b.org\/en\/"},{"@type":"ListItem","position":2,"name":"Ship2B participa en la ronda de inversi\u00f3n de tres millones de d\u00f3lares que cierra Devicare"}]},{"@type":"WebSite","@id":"https:\/\/www.ship2b.org\/#website","url":"https:\/\/www.ship2b.org\/","name":"Ship2B Foundation","description":"Adventurers for a better world","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ship2b.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"","url":"https:\/\/www.ship2b.org\/en\/actualidad\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/11725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/comments?post=11725"}],"version-history":[{"count":2,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/11725\/revisions"}],"predecessor-version":[{"id":11730,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/posts\/11725\/revisions\/11730"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/media\/11726"}],"wp:attachment":[{"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/media?parent=11725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/categories?post=11725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ship2b.org\/en\/wp-json\/wp\/v2\/tags?post=11725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}